Adaptive COVID-19 Treatment Trial Of Coronavirus Drug Combination Begins

The Adaptive COVID-19 Treatment Trial or ACTT has entered the new stage of its trial, ACTT2, which will study the potential coronavirus drug remdesivir in combination with baricitinib or placebo.

영어공부,영어뉴스,StudyEnglish,EducationalNews,yt:cc=on,latestnews,latest,news,philippines,newstoday,currentnews,newsupdate,corona,corona19,coronavirus,ncov,covid,covid19,pandemic,virus,treatment,trial,drug,drugcombination,treatmenttrial,actt,actt2,remdesivir,baricitinib,placebo,